You have 9 free searches left this month | for more free features.

Secondary Raynaud's Disease

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Raynaud Phenomenon Secondary to Systemic Sclerosis Trial in Paris (BOTOX® solution, Placebo group)

Completed
  • Raynaud Phenomenon Secondary to Systemic Sclerosis
  • BOTOX® solution
  • Placebo group
  • Paris, France
    Hôpital Tenon
Feb 9, 2022

Raynaud's Phenomenon Trial in Boston (oral treprostinil, Placebo)

Completed
  • Raynaud's Phenomenon
  • oral treprostinil
  • Placebo
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jan 5, 2022

Metabolomic Analysis of Systemic Sclerosis

Recruiting
  • Scleroderma (Limited and Diffuse)
  • +4 more
  • - Skin biopsy - Urine sample - Blood sample
  • Dijon, France
  • +3 more
Jul 7, 2022

Buerger Disease, Raynaud Syndrome Trial (BOTOX INJECTION)

Not yet recruiting
  • Buerger Disease
  • Raynaud Syndrome
  • BOTOX INJECTION
  • (no location specified)
Jan 16, 2023

Raynaud Disease, Raynaud Phenomenon, Raynaud Syndrome Trial in Minneapolis (Blue Light Therapy, Sham Light Therapy)

Not yet recruiting
  • Raynaud Disease
  • +2 more
  • Blue Light Therapy
  • Sham Light Therapy
  • Minneapolis, Minnesota
    University of Minnesota
Mar 17, 2022

Systemic Sclerosis, Fatigue, Raynaud Phenomenon Trial in Pittsburgh (Apollo)

Active, not recruiting
  • Systemic Sclerosis
  • +2 more
  • Apollo
  • Pittsburgh, Pennsylvania
    University of Pittsburgh School of Medicine
Jan 4, 2023

Raynaud's Phenomenon Secondary to Systemic Sclerosis Trial in United States (Placebo IV infusion, Iloprost Injection, for

Completed
  • Raynaud's Phenomenon Secondary to Systemic Sclerosis
  • Placebo IV infusion
  • Iloprost Injection, for intravenous use
  • Phoenix, Arizona
  • +29 more
Jul 13, 2021

Raynaud's Phenomenon Isolated Primary, Raynaud's Phenomenon (Secondary), Healthy Trial in Grenoble (Biopsy)

Completed
  • Raynaud's Phenomenon Isolated Primary
  • +2 more
  • Biopsy
  • Grenoble, Isère, France
    CHU of Grenoble Alpes
Apr 8, 2020

Raynaud Phenomenon Trial in Atlanta (Botulinum toxin)

Recruiting
  • Raynaud Phenomenon
  • Botulinum toxin
  • Atlanta, Georgia
    Emory University Hospital
Feb 10, 2022

Dermoscopy in Primary Raynaud's Phenomenon

Completed
  • Raynaud Phenomenon
  • Dermoscopy
  • Paris, France
    Hôpital de Tenon
Jul 19, 2021

Screening and Secondary Prevention Rheumatic Heart Disease Study

Recruiting
  • Rheumatic Heart Disease
    • Karachi, Sindh, Pakistan
      National Institute of Cardiovascular Diseases (NICVD)
    Aug 12, 2023

    Primary Raynaud Phenomenon Trial in Nottingham (High Flavanol Cocoa extract, Alkalised cocoa)

    Completed
    • Primary Raynaud Phenomenon
    • High Flavanol Cocoa extract
    • Alkalised cocoa
    • Nottingham, Notts, United Kingdom
      David Greenfield Human Physiology Laboratories
    Nov 3, 2021

    Systemic Sclerosis Trial in Worldwide (GS-248, Placebo)

    Completed
    • Systemic Sclerosis
    • Gent, Belgium
    • +11 more
    Aug 2, 2022

    Efficacy and Safety of Pacitol Inj.

    Recruiting
    • Chronic Kidney Disease 5D
    • Secondary Hyperparathyroidism
      • Goyang-si, Gyeonggi-do, Korea, Republic of
        DongGuk university Ilsan hospital
      Nov 6, 2023

      Parkinson Disease, Physical Therapy Modalities, Frailty Trial in Oviedo (Home Physiotherapy Group, Control Group)

      Enrolling by invitation
      • Parkinson Disease
      • +2 more
      • Home Physiotherapy Group
      • Control Group
      • Oviedo, Spain
        University of Oviedo
      Nov 7, 2022

      Raynaud Phenomenon Trial in Orlando (AbobotulinumtoxinA, Saline solution)

      Terminated
      • Raynaud Phenomenon
      • Orlando, Florida
        UCF Health Lake Nona Office
      Jun 9, 2021

      Rheumatic Heart Disease Trial in Kampala (Primary Training Phase, Primary Assessment Phase, Primary Screening Phase)

      Active, not recruiting
      • Rheumatic Heart Disease
      • Primary Training Phase
      • +5 more
      • Kampala, Uganda
        Uganda Heart Institute
      Jan 27, 2023

      Secondary Hyperparathyroidism, End Stage Kidney Disease Trial (PLS240, Placebo, Open-Label Extension PLS240)

      Not yet recruiting
      • Secondary Hyperparathyroidism
      • End Stage Kidney Disease
      • (no location specified)
      Apr 18, 2023

      Chronic Kidney Disease stage3, Chronic Kidney Disease stage4, Vitamin d Deficiency Trial (CTAP101, Placebo)

      Not yet recruiting
      • Chronic Kidney Disease stage3
      • +3 more
      • (no location specified)
      Sep 13, 2022

      Raynaud Phenomenon Trial in Grenoble (L-citrulline, Beetroot juice, L-citrulline )

      Recruiting
      • Raynaud Phenomenon
      • L-citrulline
      • +3 more
      • Grenoble, France
        Grenoble University Hospital
      May 12, 2021

      Secondary Hyperparathyroidism Trial (PLS240, Placebo, Open-Label Extension PLS240)

      Not yet recruiting
      • Secondary Hyperparathyroidism
      • (no location specified)
      Apr 17, 2023

      3T MR for Secondary Hyperparathyroidism Comparison With 4DCT

      Not yet recruiting
      • Parathyroid Gland Disease
      • Secondary Hyperparathyroidism
        • (no location specified)
        Sep 15, 2022

        Cytomegalovirus Infections, Infection in Solid Organ Transplant Recipients, Neutropenia Trial (Letermovir)

        Not yet recruiting
        • Cytomegalovirus Infections
        • +3 more
        • (no location specified)
        Jan 17, 2023

        Rheumatic Heart Disease, Rheumatic Heart Disease in Children Trial in Tulsipur (School nurse program)

        Recruiting
        • Rheumatic Heart Disease
        • Rheumatic Heart Disease in Children
        • School nurse program
        • Tulsipur, Nepal
          Tulsi Secondary Boarding School
        Aug 15, 2022

        Coronary Artery Disease Trial in Hasselt (Smartphone application)

        Completed
        • Coronary Artery Disease
        • Smartphone application
        • Hasselt, Limburg, Belgium
          Jessa Hospital
        Sep 5, 2022